Xoma | XOMA - Ordinary Share Capital

Stock Price
37.90
Daily Change
0.01 0.03%
Monthly
25.50%
Yearly
57.00%
Q2 Forecast
37.09

Xoma reported $87K in Ordinary Share Capital for its fiscal quarter ending in June of 2024.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Agenus USD 35.32M 2.51M Dec/2025
Agios Pharmaceuticals USD 58.45M 169K Dec/2025
Ardelyx USD 244.35M 1.38M Dec/2025
aTyr Pharma USD 16.65M 81.34M Dec/2025
BioMarin Pharmaceutical USD 192.3M 201K Dec/2025
Celldex Therapeutics USD 66.55M 102K Dec/2025
Curis USD 12.93M 12.87M Dec/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Emergent BioSolutions USD 100K 0 Jun/2023
Incyte USD 198.46M 2.33M Dec/2025
MacroGenics USD 63.32M 60K Dec/2025
Novartis USD 1.91B 10.64M Dec/2025
Novartis USD 1.91B 10.64M Dec/2025
Pfizer USD 5.69B 1000K Sep/2025
Prothena USD 53.83M 3K Dec/2025
Regeneron Pharmaceuticals USD 105.3M 1.1M Sep/2025
Xoma USD 87K 1000 Jun/2024